Physician
Coastal Bend Womens Center
Coastal Bend Womens Center was paid $11.61M by Medicaid between May 2018 and Dec 2024, across 87 billing codes. Its largest line is 59409, Vaginal delivery only (with or without episiotomy and/or forceps) — 17% of everything it billed.
33Billing provider infoCOASTAL BEND WOMENS CENTER
CORPUS CHRISTI, TX 78412
CORPUS CHRISTI, TX 78412
33aNPI1891812483assigned 03/26/2007
33bProvider typeObstetrics & Gynecology Physician
28Total paid$11.61M
24GClaims358,102
24DCodes billed87
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Texas
Rank by total paid#5 of 432
Median peer was paid$103K
This provider vs. median113×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24 | $1K | |
| 2019 | 24,938 | $545K | |
| 2020 | 14,722 | $409K | |
| 2021 | 75,335 | $2.60M | |
| 2022 | 84,404 | $2.71M | |
| 2023 | 86,819 | $2.93M | |
| 2024incomplete | 71,860 | $2.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 17% | 3,049 | 3,016 | $1.93M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 32,604 | 22,796 | $1.76M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 9.7% | 12,449 | 10,995 | $1.13M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.2% | 27,933 | 21,588 | $1.07M |
| 76819 | Fetal biophysical profile; without non-stress testing | 3.7% | 5,988 | 3,413 | $432K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 3.5% | 3,504 | 3,427 | $404K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.3% | 13,944 | 13,641 | $389K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.3% | 13,919 | 13,624 | $389K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 3.3% | 6,423 | 6,252 | $382K |
| 59514 | 3.1% | 548 | 542 | $354K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.0% | 6,923 | 6,748 | $353K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2.4% | 3,535 | 3,115 | $276K |
75 more codes
| 59430 | 2.2% | 2,330 | $253K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.0% | 12,250 | $238K |
| 86780 | 1.6% | 17,054 | $182K | |
| 87800 | 1.5% | 4,865 | $178K | |
| 99215 | Doctor's office visit, returning patient (complex) | 1.5% | 1,955 | $171K |
| 76813 | 1.3% | 1,493 | $154K | |
| 87653 | 1.3% | 5,258 | $151K | |
| 90715 | 1.2% | 3,142 | $145K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 19,321 | $121K |
| 81003 | <1% | 62,266 | $112K | |
| 87340 | <1% | 11,128 | $90K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 589 | $75K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,181 | $73K |
| 86762 | <1% | 5,600 | $65K | |
| 76830 | Ultrasound, transvaginal | <1% | 616 | $59K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,120 | $57K |
| 87088 | <1% | 8,391 | $55K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 636 | $53K |
| 86850 | <1% | 6,023 | $47K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,530 | $46K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 685 | $44K |
| 86803 | <1% | 3,293 | $35K | |
| 99000 | <1% | 2,859 | $35K | |
| 90686 | <1% | 1,562 | $31K | |
| 87081 | <1% | 5,325 | $29K | |
| 86696 | <1% | 1,360 | $22K | |
| 82950 | <1% | 5,255 | $20K | |
| 76818 | <1% | 170 | $18K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 620 | $15K |
| 86695 | <1% | 1,364 | $15K | |
| 81001 | <1% | 6,729 | $15K | |
| 59025 | Fetal non-stress test | <1% | 430 | $14K |
| 86900 | <1% | 5,523 | $13K | |
| 86901 | <1% | 5,538 | $13K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 133 | $13K |
| 84439 | <1% | 1,795 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 830 | $11K |
| 99234 | <1% | 70 | $8K | |
| 80053 | Comprehensive metabolic panel | <1% | 914 | $8K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 100 | $6K |
| 87480 | <1% | 460 | $5K | |
| 87510 | <1% | 460 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 69 | $5K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 123 | $4K |
| 90658 | <1% | 189 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 134 | $4K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 231 | $2K |
| 82951 | <1% | 204 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 69 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 96 | $2K |
| 76801 | <1% | 17 | $1K | |
| 80061 | Lipid panel | <1% | 116 | $1K |
| 84702 | <1% | 96 | $1K | |
| 54150 | <1% | 12 | $1K | |
| 83615 | <1% | 200 | $928.53 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 110 | $824.69 |
| 84550 | <1% | 200 | $688.63 | |
| 84703 | <1% | 118 | $665.17 | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 16 | $604.92 |
| 99217 | <1% | 12 | $582.47 | |
| 84146 | <1% | 24 | $347.63 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $320.04 |
| 99001 | <1% | 68 | $265.10 | |
| 83525 | <1% | 25 | $223.69 | |
| 84403 | <1% | 12 | $217.91 | |
| S8301 | Infection control supplies, not otherwise specified | <1% | 51 | $216.88 |
| 82627 | <1% | 12 | $187.66 | |
| 81002 | <1% | 48 | $137.24 | |
| 82947 | <1% | 42 | $122.12 | |
| 87186 | <1% | 13 | $78.48 | |
| 0500F | 0% | 3,446 | $0.00 | |
| 0501F | 0% | 287 | $0.00 | |
| 0503F | 0% | 2,184 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 638 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 186 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRODRIGUEZ, LEO (MANAGING PARTNER)